from Reuters: Business News https://ift.tt/2CDx2m3
Monday, September 10, 2018
Monday, September 10, 2018
MZ Digital Marketing Agency
BUSINESS NEWS
No comments
Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).

from Reuters: Business News https://ift.tt/2CDx2m3
from Reuters: Business News https://ift.tt/2CDx2m3
Related Posts:
LATEST BUSINESS NEWSCatch all the live market action here from Home Page https://ift.tt/2SEcFJy … Read More
LATEST BUSINESS NEWSSources privy to development said the government had sent at least three letters on different issues under Section 7 of the RBI Act from Home Page https://ift.tt/2DgOGM5 … Read More
LATEST BUSINESS NEWSSources privy to development said the government had sent at least three letters on different issues under Section 7 of the RBI Act from Home Page https://ift.tt/2DgOGM5 … Read More
LATEST BUSINESS NEWSSHANGHAI (Reuters) - Asian shares jumped on Friday after a phone call between the U.S. and Chinese presidents raised hopes of a thaw in trade tensions, but gains were checked by signs of slowing global growth and a warning fr… Read More
LATEST BUSINESS NEWSCatch all the live market action here from Home Page https://ift.tt/2SEcFJy … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment